GlassScriptPhysician profile
Perry W Sexton
NPI 1972665339
$5,584.71
in general payments reported to CMS, 2019-2025
44 companies · $664 in 2025
The $664 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $305 · 2021: $780 · 2022: $1,083 · 2023: $1,283 · 2024: $1,161 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,108.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,317.16 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Indivior INC. | $684.10 | 2019-2025 | Sublocade |
| Supernus Pharmaceuticals, INC. | $429.41 | 2022-2024 | Qelbree, Qelbree, Xyosted |
| Novo Nordisk INC | $406.02 | 2021-2025 | Rybelsus, Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $272.60 | 2019-2025 | Trintellix |
| Allergan, INC. | $190.79 | 2019-2020 | |
| Alkermes, INC. | $179.59 | 2021-2025 | Vivitrol, Vivitrol |
| Seqirus USA INC | $164.34 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent, Fluad Quadrivalent |
| Pfizer INC. | $163.11 | 2019-2025 | |
| Lilly USA, LLC | $162.84 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $148.39 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $102.56 | 2022 | |
| Bausch Health US, LLC | $90.79 | 2022 | |
| Exact Sciences Corporation | $83.84 | 2023-2024 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $77.80 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Sexton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.